STEM
Paulo N. has a diverse and extensive work experience in the healthcare industry. Paulo currently holds the position of Director (EU West/Iberia) in Business Development and Sales & Marketing Strategy at STEM Healthcare since March 2021. Prior to that, they served as the US Director in the same field at STEM Healthcare from May 2018 to March 2021.
Before joining STEM Healthcare, Paulo worked at Endo Pharmaceuticals from November 2017 to May 2018, where they focused on Men's Health/Oncology Marketing.
From 2011 to 2017, Paulo held various marketing roles at AstraZeneca, including Launch Brand all channels, Consumer Marketing, HCP Promotional Campaigns, KOL Engagements, and District Sales Manager.
Their career in the healthcare industry started in 1999 when they worked as a Territory Sales Manager at Altria.
Furthermore, they spent several years at Novartis, beginning in 2002, where they held the positions of Senior Sales Consultant and District Sales Manager, leading sales teams and managing product portfolios.
Paulo N. attended Rutgers University from 1995 to 1999, where they earned a Bachelor of Science degree in Marketing/Business Management.
This person is not in any offices
STEM
STEM is part of Inizio Advisory, a trusted advisor for pharmaceutical, life science and healthcare companies at every stage of the product and patient journey. Through Advisory’s data driven approach and connected intelligence and solutions, Inizio Advisory helps accelerate clinical and commercial success, creating long term value for clients and their patients. Since 2007, STEM has been helping life science companies optimize the commercial performance by measuring the alignment between their brand strategy and execution at every stage of the product stage of the product lifecycle. We do this through our objective industry insights, robust benchmarking data, and a proven methodology, helping clients to improve return on investment, drive greater customer engagement, accelerate their brands performance and ensure world-class medicines reach the right patients.